Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free
Close

Morphosys AG O.N. (MORG)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
18.170 -0.410    -2.21%
23/09 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  DE0006632003 
WKN:  663200
  • Prev. Close: 18.170
  • Open: 18.785
  • Day's Range: 17.800 - 18.785
Morphosys AG 18.170 -0.410 -2.21%

MORG Balance Sheet

 
Featured here, the Balance Sheet for Morphosys AG O.N., which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2021
31/12
2021
30/09
2021
30/06
2021
31/03
Total Current Assets 1132.97 1294.76 1255.91 1257.38
Cash and Short Term Investments 993.66 1155.19 1095.34 1122.26
Cash 123.25 249.77 297.33 109.59
Cash & Equivalents - 249.77 297.33 109.59
Short Term Investments 870.42 905.43 798.01 1012.67
Total Receivables, Net 79.23 82.07 108.19 104.17
Accounts Receivables - Trade, Net 75.91 77.04 97.17 101.3
Total Inventory 20.76 13.27 14.52 13.4
Prepaid Expenses 39.32 44.23 37.85 17.55
Other Current Assets, Total - - - -
Total Assets 2556.25 2883.94 1577.41 1649.91
Property/Plant/Equipment, Total - Net 49.59 51.92 49.42 49.92
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net 335.57 570.96 1.62 1.62
Intangibles, Net 838.32 787.91 79.03 69.04
Long Term Investments - - 55.38 125.71
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 199.8 178.4 136.06 146.23
Other Assets, Total - - - -
Total Current Liabilities 284.54 259.12 204.55 202.26
Accounts Payable - - - -
Payable/Accrued 188.08 168.4 134.66 124.3
Accrued Expenses - - - -
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 3.66 4.09 3.68 4.03
Other Current liabilities, Total 92.8 86.63 66.21 73.94
Total Liabilities 2311.38 2286.69 976.01 1070.25
Total Long Term Debt 322.13 320.18 318.27 316.63
Long Term Debt 282.78 280.22 277.68 275.19
Capital Lease Obligations 39.35 39.97 40.59 41.44
Deferred Income Tax 22.07 23.86 5.06 2.33
Minority Interest - - - -
Other Liabilities, Total 1682.64 1683.53 448.13 549.03
Total Equity 244.88 597.25 601.41 579.65
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 34.23 34.23 32.89 32.89
Additional Paid-In Capital 833.32 832.58 749.28 749.85
Retained Earnings (Accumulated Deficit) -672.35 -291.38 -178.6 -199.5
Treasury Stock - Common -3.09 -3.37 -3.78 -4.87
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 52.76 25.18 1.62 1.28
Total Liabilities & Shareholders' Equity 2556.25 2883.94 1577.41 1649.91
Total Common Shares Outstanding 34.15 34.14 32.79 32.76
Total Preferred Shares Outstanding - - - -
* In Millions of EUR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MORG Comments

Write your thoughts about Morphosys AG O.N.
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
gowtham kotha
gowtham kotha Jun 29, 2022 8:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why its going down
Robert Laszlo
Robert Laszlo Aug 18, 2021 11:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
from now it will move up above 50 ...
Fab De
Fab___De Aug 18, 2021 11:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Obviously you were wrong.
Robert Laszlo
Robert Laszlo Aug 18, 2021 11:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
in Aug moved up over 50 and i sold all shares at 49.88... now i dont care
Bm Bendary
Bm Bendary Aug 02, 2021 7:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I wounder why the stock has been hit so hard? Its almost @50% ot march last year when the entire market crashed!! I dont beleive lowering the upper limit of the FY revenue guidance is the driver. I have to say that ive not spent quality time understanding the fundamental of this company, i only strated to follow it recently. Appreciate your insights. Thanks
Doe John
Doe John Jul 26, 2021 2:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any idea?
Jon Lovbacka
Jon Lovbacka Jul 26, 2021 2:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Announced a narrowing of revenue guidance. There are better options out there, but today might be a good entry point as the negative reaction (incl. yesterday) seems excessive.
george bush
george bush Apr 21, 2021 9:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://ch.marketscreener.com/kurs/aktie/MORPHOSYS-AG-436425/news/COMPANY-TALK-J-J-nbsp-41-Prozent-Plus-mit-Morphosys-Wirkstoff-33013409/
george bush
george bush Apr 12, 2021 8:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
strong buy
george bush
george bush Mar 25, 2021 1:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
European approval for tafasitamab is due at the end of May
Bert Muermans
Bert Muermans Mar 15, 2021 5:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Damn good results published!!!
Bert Muermans
Bert Muermans Mar 15, 2021 1:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
When (what time)  is the news public concerning their yearresults?
george bush
george bush Mar 15, 2021 7:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy buy buy
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email